Skip to Content
Merck
CN
  • Unraveling the regulatory connections between two controllers of breast cancer cell fate.

Unraveling the regulatory connections between two controllers of breast cancer cell fate.

Nucleic acids research (2014-05-06)
Jinho Lee, Abhinav Tiwari, Victor Shum, Gordon B Mills, Michael A Mancini, Oleg A Igoshin, Gábor Balázsi
ABSTRACT

Estrogen receptor alpha (ERα) expression is critical for breast cancer classification, high ERα expression being associated with better prognosis. ERα levels strongly correlate with that of GATA binding protein 3 (GATA3), a major regulator of ERα expression. However, the mechanistic details of ERα-GATA3 regulation remain incompletely understood. Here we combine mathematical modeling with perturbation experiments to unravel the nature of regulatory connections in the ERα-GATA3 network. Through cell population-average, single-cell and single-nucleus measurements, we show that the cross-regulation between ERα and GATA3 amounts to overall negative feedback. Further, mathematical modeling reveals that GATA3 positively regulates its own expression and that ERα autoregulation is most likely absent. Lastly, we show that the two cross-regulatory connections in the ERα-GATA3 negative feedback network decrease the noise in ERα or GATA3 expression. This may ensure robust cell fate maintenance in the face of intracellular and environmental fluctuations, contributing to tissue homeostasis in normal conditions, but also to the maintenance of pathogenic states during cancer progression.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Monoclonal Anti-β-Actin antibody produced in mouse, clone AC-15, ascites fluid
Sigma-Aldrich
MISSION® esiRNA, targeting human GATA3
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Gata3
Sigma-Aldrich
Anti-Estrogen Receptor α Antibody, clone 60C, rabbit monoclonal, culture supernatant, clone 60C, from rabbit